All In Biotech

Free tool

FAERS Monitor: Nicorette

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 018612 or its brand name (Nicorette, Nicotine Polacrilex). Reports on generic versions are filed under their own applications.

Reports

21,925

Serious

3,984

18% of reports

Hospitalization

924

Death reported

149

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective3,651
  • nicotine dependence3,383
  • intentional drug misuse3,276
  • nausea1,926
  • drug administration error1,140
  • malaise1,015
  • oral discomfort715
  • dizziness703
  • dyspepsia662
  • wrong technique in product usage process656
  • product quality issue652
  • headache633
  • vomiting620
  • throat irritation614
  • hiccups598

Reports by year received

View as table
YearReports
2004115
2005223
20061,148
20071,347
20081,063
20091,094
20101,044
20111,453
20121,517
20131,109
2014233
20151,570
20161,309
20171,308
20181,145
20191,038
2020921
20211,062
2022811
2023725
2024600
2025707
2026383

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,032,234 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
nicotine dependenceSignal3,383737.1706.21,406,333
intentional drug misuseSignal3,276178.0171.9486,733
hiccupsSignal59875.369.440,598
oral discomfortSignal71552.048.333,884
drug administration errorSignal1,14037.034.938,436
throat irritationSignal61413.312.36,889
dyspepsiaSignal6626.56.03,064
product quality issueSignal6524.64.31,850
wrong technique in product usage processSignal6563.12.9944
drug ineffectiveSignal3,6512.72.64,029
nauseaSignal1,9262.32.21,527
malaiseSignal1,0152.22.1695
dizziness7031.41.366
vomiting6201.31.235
headache6331.00.91

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.